Cargando…

Fatal Rhabdomyolysis in a Patient with Liver Cirrhosis after Switching from Simvastatin to Fluvastatin

HMG-CoA reductase inhibitors (statins) are widely used to treat hypercholesterolemia. Among the adverse effects associated with these drugs are statin-associated myopathies, ranging from asymptomatic elevation of serum creatine kinase to fatal rhabdomyolysis. Fluvastatin-induced fatal rhabdomyolysis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baek, Seung Don, Jang, Sun-Joo, Park, So-Eun, Ok, Tae Jin, Leem, Jaechan, Lee, Ho-Su, Park, So Jung, Kim, Tae Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2011
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230026/ https://www.ncbi.nlm.nih.gov/pubmed/22148003 http://dx.doi.org/10.3346/jkms.2011.26.12.1634

Ejemplares similares

Simvastatin: Rhabdomyolysis: case report
Publicado: (2020)

Simvastatin and fluvastatin attenuate trauma-induced cell death and catabolism in human cartilage
por: Riegger, Jana, et al.
Publicado: (2022)

Simvastatin Sodium Salt and Fluvastatin Interact with Human Gap Junction Gamma-3 Protein
por: Marsh, Andrew, et al.
Publicado: (2016)

Sitagliptin and Simvastatin Interaction Causing Rhabdomyolysis and AKI
por: Patel, Chinmay, et al.
Publicado: (2019)

Rhabdomyolysis caused by an unusual interaction between azithromycin and simvastatin
por: Alreja, Gaurav, et al.
Publicado: (2012)

Fatal Rhabdomyolysis in a Patient with Head Injury
por: Park, Yong Jin, et al.
Publicado: (2013)

Clostridioides difficile Induced Rhabdomyolysis Associated With Decompensated Cirrhosis
por: Dungan, William, et al.
Publicado: (2022)

Severe Rhabdomyolysis Associated with Simvastatin and Role of Ciprofloxacin and Amlodipine Coadministration
por: De Schryver, Nicolas, et al.
Publicado: (2015)

Rhabdomyolysis after ezetimibe/simvastatin therapy in an HIV-infected patient
por: Chanson, Noemie, et al.
Publicado: (2008)

Enantiospecific Pharmacogenomics of Fluvastatin
por: Hirvensalo, Päivi, et al.
Publicado: (2019)

Sauna-Induced Fatal Rhabdomyolysis
por: Zhuo, Min, et al.
Publicado: (2018)

Palbociclib in combination with simvastatin induce severe rhabdomyolysis: a case report
por: Nersesjan, Vardan, et al.
Publicado: (2019)

Pioglitazone/simvastatin: Acute kidney injury secondary to rhabdomyolysis: case report
Publicado: (2021)

Severe rhabdomyolysis and acute renal failure secondary to the use of simvastatin in undiagnosed hypothyroidism
por: Qari, F. A.
Publicado: (2008)

First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin
por: Fuah, Kar Wah, et al.
Publicado: (2021)

Rifaximin as a rare cause of rhabdomyolysis in cirrhosis
por: Rezigh, Alec B., et al.
Publicado: (2018)

The Difference in Pharmacokinetics and Pharmacodynamics between Extended-Release Fluvastatin and Immediate-Release Fluvastatin in Healthy Chinese Subjects
por: Xu, H. R., et al.
Publicado: (2012)

Pheniramine Maleate-Induced Rhabdomyolysis and Aki: Is it Fatal?
por: Venugopal, K, et al.
Publicado: (2014)

Adolescent COVID-19-Associated Fatal Rhabdomyolysis
por: Anwar, Huda, et al.
Publicado: (2020)

Interaction between Mitochondria and the Endoplasmic Reticulum: Implications for the Pathogenesis of Type 2 Diabetes Mellitus
por: Leem, Jaechan, et al.
Publicado: (2012)

Effects of Fluvastatin on the Pharmacokinetics of Repaglinide: Possible Role of CYP3A4 and P-glycoprotein Inhibition by Fluvastatin
por: Lee, Chong-Ki, et al.
Publicado: (2013)

Acute Rhabdomyolysis Associated with Coadministration of Levofloxacin and Simvastatin in a Patient with Normal Renal Function
por: Paparoupa, Maria, et al.
Publicado: (2014)

Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report
por: Poumeaud, François, et al.
Publicado: (2022)

Fatal Hyperosmolar Hyperglycaemic Syndrome complicated by severe Rhabdomyolysis
por: Joseph, Amer, et al.
Publicado: (2012)

Guillain-Barre syndrome complicated by acute fatal rhabdomyolysis
por: Saxena, Amrish, et al.
Publicado: (2014)

Fatal Statin-Induced Rhabdomyolysis by Possible Interaction with Palbociclib
por: Nelson, Kellie Lynn, et al.
Publicado: (2017)

Fatal Rhabdomyolysis in a COVID-19 Patient on Rosuvastatin
por: Anklesaria, Zafia, et al.
Publicado: (2020)

Fatal Case of Rhabdomyolysis Post-COVID-19 Vaccine
por: Ajmera, Kunal M
Publicado: (2021)

Corrigendum: Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report
por: Poumeaud, François, et al.
Publicado: (2023)

Kinetic Spectrophotometric Determination of Fluvastatin in Pharmaceutical Preparations
por: Ashour, Safwan, et al.
Publicado: (2010)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

Protective Effects of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, against Cisplatin-Induced Nephrotoxicity in Mice
por: Choi, Seung Hee, et al.
Publicado: (2017)

Fluvastatin Prevents Lung Adenocarcinoma Bone Metastasis by Triggering Autophagy
por: Yang, Zuozhang, et al.
Publicado: (2017)

Simvastatin treatment boosts benefits of apoptotic cell infusion in murine lung fibrosis
por: Lee, Ye-JI, et al.
Publicado: (2017)

Synergistic Effects of Simvastatin and Irinotecan against Colon Cancer Cells with or without Irinotecan Resistance
por: Jang, Hyun Joo, et al.
Publicado: (2016)

Fatal Accelerated Cirrhosis after Imported HEV Genotype 4 Infection
por: Perumpail, Ryan B., et al.
Publicado: (2015)

Inhibition of Candida albicans by Fluvastatin Is Dependent on pH
por: Schmidt, Martin, et al.
Publicado: (2009)

Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers
por: El-Helw, Abdel-Rahim M, et al.
Publicado: (2015)

Rhabdomyolysis and Neuroleptic Malignant Syndrome Associated with Very Low-dose Antipsychotics in Children and Adolescent
por: Park, Jong-Il, et al.
Publicado: (2019)

Disseminated Mycobacterium intracellulare Infection in an Immunocompetent Host
por: Kim, Won-Young, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8ehk52iph8noj5ovo0atg4n5ht